安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Pfizer: One of the worlds premier biopharmaceutical companies
Pfizer RxPathways Pfizer RxPathways connects eligible patients to a range of assistance programs that offer insurance support, co-pay help, and medicines for free or at a savings
- Pfizer’s Core Values of Social Responsibility and Philanthropy
The Best Get Better—Pfizer and Warner-Lambert merge to form the new Pfizer, creating the world's fastest-growing major pharmaceutical company Learn more about the Pfizer Warner-Lambert merger
- Pfizer Company Fact Sheet | Key Pharma Consumer Health Products | Pfizer
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives We strive to set the standard for quality, safety, and value in the discovery, development, and manufacture of health care products Our global portfolio includes medicines and vaccines as well as many of the world's best-known consumer health care products
- Our Products: Holding the Promise of a Breakthrough | Pfizer
In this section find an overview of our Pfizer Products and search for information on our most popular Pfizer products Our products are the results of 1500 scientists overseeing more than 500,000 lab tests and over 36 clinical trials before the first prescription
- Our Science: Pharmaceutical Development | Pfizer | Pfizer
At Pfizer our biotechnology is our foundation With 25,000 clinical researchers testing everyday, pharmaceutical development and innovation are our focus Learn more
- Newsroom - Pfizer
Pfizer surveyed adults in 10 countries across the Global North and South to better understand the general population's trust in incorporating technology into the management of their healthcare The results showed that 6 in 10 trust technology in this setting but that means 4 in 10 are at risk of being left behind
- Pfizer’s Phase 2 Study of Trispecific Antibody Positive in Moderate to . . .
This release contains forward-looking information abouttilrekimig (PF-07275315), an investigational trispecific antibody, including its potential benefits; results from the Phase 2 study of tilrekimig in participants with moderate to severe atopic dermatitis; Pfizer’s investigational inflammation and immunology portfolio, and anticipated
- Press Releases - Pfizer
Pfizer Invites Public to View and Listen to Webcast of May 5 Conference Call with Analysts Financial Finance 03 23 2026 Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial Research and Pipeline Research 03 20 2026 Pfizer Recommends Shareholders Reject the Mini-Tender Offer by Tutanota LLC
|
|
|